3 bagger, page-10

alzheimers is an expensive disease for governments

carers,hostels, nursing doctors etc

it is a very demanding disease with able bodied people that need constant supervision

the current drugs to treat it are already $50-100pm

and provide symptomatic relief only

if a new drug comes along that not only rlieves symptoms
but modifies the future course of the disease

its value will not only be to those it treats but to the governments that foot the bill for current management

the families of sufferers would consider it priceless